Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,354
Closed -$230K 1729
2026
Q1
$230K Buy
+16,354
New +$196K ﹤0.01% 1479
2024
Q1
Sell
-11,363
Closed -$118K 1897
2023
Q4
$118K Sell
11,363
-2,539
-18% -$24K ﹤0.01% 1845
2023
Q3
$156K Sell
13,902
-3,372
-20% -$42.4K ﹤0.01% 1775
2023
Q2
$199K Sell
17,274
-4,471
-21% -$55.8K ﹤0.01% 1782
2023
Q1
$302K Buy
21,745
+8,650
+66% +$124K ﹤0.01% 1680
2022
Q4
$172K Buy
+13,095
New +$175K ﹤0.01% 1827

Other funds holding EHAB

Guggenheim Capital's EHAB Position: Q2 2026 in Review

Guggenheim Capital sold out of Enhabit (EHAB) in Q2 2026, closing a stake of 16,354 shares — an estimated $230K sold.

Guggenheim Capital first reported a position in EHAB in Q4 2022 and held it in 6 quarters. The position peaked at $302K in Q1 2023. 1 fund tracked by Wall St. Rank holds EHAB as of Q2 2026.

  • Guggenheim Capital reported no remaining Enhabit position as of Q2 2026 after selling out during the quarter.
  • Guggenheim Capital sold 16,354 Enhabit shares in Q2 2026, an estimated $230K.
  • Guggenheim Capital first reported a position in Enhabit in Q4 2022 and held it in 6 quarters.
  • Guggenheim Capital's Enhabit position peaked at $302K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Enhabit as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.